genomica –

Boulder, Colo.

Went public 9/29/2000 at $19 per share

Filing Range: 6.44 mil. shares @ $16 to $18

Shares Outstanding: 20.989 mil. shares

Underwriters: CIBC World Markets/Dain Rauscher Wessels/

Prudential Vector Healthcare

Company Counsel: Cooley Godward LLP

Manager Counsel: McDermott Will & Emery

Auditor: Arthur Andersen & Co.

The Company:

Develops software that helps scientists in computer-aided gene discovery and functional analysis. The company’s software allows scientists to drive the gene discovery and functional analysis process faster and more efficiently.

Venture Backers:

Harris & Harris Group

HarbourVest Partners LLC

Invesco Private Capital

ARCH Venture Partners

Boulder Ventures Ltd.

Pegasus Ventures

Financing Rounds:

Number of Round Amt.

Round # Round Date Stage Investors ($ thousands)

1 10/03/1997 6 Early Stage 7500.0

2 02/01/2000 7 Later Stage 13600.0

3 03/01/2000 1 Later Stage 15034.0


(Data in $ millions)



Total Revenues: $0.8

Net Income: -7.6